It is common for breast cancer patients to highly express female hormone receptors, including estrogen receptor (ER) and progesterone receptor (PR), or/and human epidermal growth factor receptor 2 (HER-2), which are biomarkers for the treatment of breast cancer in targeted therapy [6]. This evidence concerns the gene NR4A1 and breast cancer.